We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.59B
AUM Growth
-$78.5M
Cap. Flow
-$53.5M
Cap. Flow %
-1.49%
Top 10 Hldgs %
13.47%
Holding
1,643
New
159
Increased
579
Reduced
611
Closed
173

Top Buys

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$52.5M
2
AFL icon
Aflac
AFL
+$24.1M
3
WLY icon
John Wiley & Sons Class A
WLY
+$18.9M
4
KMX icon
CarMax
KMX
+$17.5M
5
BIIB icon
Biogen
BIIB
+$16.9M

Sector Composition

Rank Sector Weight
1 Healthcare 15.39%
2 Energy 10.37%
3 Financials 10.35%
4 Technology 9.89%
5 Industrials 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BKNG icon
501
Booking.com
BKNG
$149B
$1.46M 0.04%
31,725
-36,725
-54% -$1.75M
CYBR
502
DELISTED
CyberArk
CYBR
$1.46M 0.04%
23,211
-434
-2% -$27.8K
NFG icon
503
National Fuel Gas
NFG
$7.78B
$1.46M 0.04%
24,751
-9,998
-29% -$631K
ARRS
504
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$1.46M 0.04%
47,542
-46
-0.1% -$1.49K
SCG
505
DELISTED
Scana
SCG
$1.46M 0.04%
28,714
+4
+0% +$211
PLD icon
506
Prologis
PLD
$135B
$1.45M 0.04%
39,177
+3,219
+9% +$131K
GPC icon
507
Genuine Parts
GPC
$17.2B
$1.45M 0.04%
16,219
-4,755
-23% -$438K
XRX icon
508
Xerox
XRX
$392M
$1.45M 0.04%
51,762
-8,618
-14% -$267K
EFAV icon
509
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.35B
$1.45M 0.04%
+22,158
New +$1.5M
ET icon
510
Energy Transfer Partners
ET
$70.2B
$1.44M 0.04%
44,914
-28,642
-39% -$960K
IQV icon
511
IQVIA
IQV
$38.8B
$1.43M 0.04%
19,701
+1,721
+10% +$118K
PPH icon
512
VanEck Pharmaceutical ETF
PPH
$960M
$1.43M 0.04%
20,153
-4,590
-19% -$331K
OZK icon
513
Bank OZK
OZK
$5.6B
$1.43M 0.04%
31,146
+3,004
+11% +$128K
B
514
Barrick Mining
B
$61.7B
$1.42M 0.04%
133,261
-26,612
-17% -$324K
LUMN icon
515
Lumen
LUMN
$6.58B
$1.42M 0.04%
48,343
-3,556
-7% -$121K
SIAL
516
DELISTED
SIGMA - ALDRICH CORP
SIAL
$1.42M 0.04%
10,175
+575
+6% +$79.9K
FXO icon
517
First Trust Financials AlphaDEX Fund
FXO
$1.13B
$1.42M 0.04%
59,642
+2,299
+4% +$55K
FL
518
DELISTED
Foot Locker
FL
$1.41M 0.04%
21,030
+405
+2% +$25.3K
LQD icon
519
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
$1.41M 0.04%
12,176
-6,903
-36% -$818K
GNRC icon
520
Generac Holdings
GNRC
$11.7B
$1.41M 0.04%
35,371
-2,134
-6% -$92.2K
OII icon
521
Oceaneering
OII
$4.86B
$1.41M 0.04%
+30,190
New +$1.59M
WR
522
DELISTED
Westar Energy Inc
WR
$1.41M 0.04%
41,098
WTS icon
523
Watts Water Technologies
WTS
$11.6B
$1.41M 0.04%
27,105
-1,774
-6% -$96.4K
BKD icon
524
Brookdale Senior Living
BKD
$3.46B
$1.4M 0.04%
40,356
+5,780
+17% +$213K
RMTI icon
525
Rockwell Medical
RMTI
$28.3M
$1.4M 0.04%
789
+25
+3% +$31.8K

Similar funds

Oppenheimer & Co's Q2 2015 Portfolio in Review

As of Q2 2015, Oppenheimer & Co held 1,643 positions worth $3.59B, down 2.1% from $3.67B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Oppenheimer & Co's Q2 2015 filing shows 159 new, 579 increased, 611 reduced and 173 closed positions. Its largest new stake was Southwestern Energy Company: 251,114 shares worth $5.71M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $70.4M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Energy and Financials.

  • Oppenheimer & Co's largest Q2 2015 buy was Southwestern Energy Company: 251,114 shares worth $5.71M.
  • Oppenheimer & Co added most to Gilead Sciences in Q2 2015, an estimated $52.5M increase.
  • Oppenheimer & Co's biggest Q2 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $70.4M.
  • Oppenheimer & Co fully exited Vanguard Total Bond Market in Q2 2015, selling an estimated $12.6M.
  • Oppenheimer & Co's ten largest holdings make up 13% of its $3.59B portfolio in Q2 2015.
  • Oppenheimer & Co opened 159 new positions and closed 173 in Q2 2015.
  • Oppenheimer & Co's portfolio value fell 2.1% quarter-over-quarter to $3.59B.

Based on Oppenheimer & Co's 13F filing for Q2 2015, filed 12 Aug 2015.